Industry News
Improving The Outcome For Patients With Diseases Whose Treatment Requires Ex Vivo Cell Processing
Dec 06, 2012
Researchers at Rice University have found a way to kill some diseased cells and treat others in the same sample at the same time. The process activated by a pulse of laser light leaves neighboring healthy cells untouched... Read More
Rapid Evaluation For Swallowing And Voice Problems Recommended After Brain Surgery
Dec 06, 2012
Johns Hopkins experts are recommending early post-surgical assessment -- preferably within 24 hours -- for trouble chewing and swallowing food, or speaking normally, among patients who have had benign tumors removed from the base of the brain. Such early assessments, they say, may minimize complications associated with the sometimes hazelnut-sized tumors, called vestibular schwannomas... Read More
Experimental Pfizer Drug Slows Down Late Stage Breast Cancer
Dec 06, 2012
An experimental new drug by Pfizer has been proven to eliminate progression of an incurable form of breast cancer for over two years, according to new research presented at the San Antonio Breast Cancer Symposium. Patients were given the medicine, called PD 0332991, with Novartis (NOVN) AG's Femara. The findings reveal no tumor advancement for a median of 26.1 months, compared with 7... Read More
Annual Report On State Of Clinical Cancer Science Issued By ASCO
Dec 06, 2012
The American Society of Clinical Oncology (ASCO) has just released its annual report on the top cancer advances of the year. Clinical Cancer Advances 2012: ASCO's Annual Report on Progress Against Cancer, highlights major achievements in precision medicine, cancer screening and overcoming treatment resistance... Read More
Breath Test Can Detect Colon Cancer
Dec 05, 2012
An effective and timely examination method for colorectal cancer has remained a gerontologist's dream for many years. A method such as a breath test, similar to a breathalyser test for drinking and driving, may make it easier to diagnose colon cancer, according to a new study in the British Journal of Surgery... Read More
Aspirin Resistance Is Extremely Rare
Dec 05, 2012
Pharmacological resistance to aspirin is very rare, despite various estimates that have been put forward over the last few years, researchers from the University of Pennsylvania reported in the journal Circulation. The authors say that the incidence of aspirin resistance is so low as to be considered nonexistent... Read More
New Combination Therapy That Increases Progression-Free Survival In Hormone-Receptor-Positive Breast Cancer Patients
Dec 05, 2012
Researchers from the Revlon/UCLA Women's Cancer Research Program at UCLA's Jonsson Comprehensive Cancer Center (JCCC) reported an encouraging increase in progression-free survival (PFS, the length of time a patients is on treatment without tumor growth) for patients with breast cancer that was estrogen receptor positive (ER+), HER2-negative who were given a combination of the s... Read More
International Conference Will Show How Resveratrol Can Prevent Cancer, Heart Disease And Diabetes
Dec 05, 2012
University of Leicester scientists will present groundbreaking new evidence about how a chemical found in red wine can help prevent cancer on Wednesday, December 5. Experts from around the world are set to attend Resveratrol 2012, a major conference at the University which will assess the latest advances in the study of resveratrol - a compound found in the skins of red grapes... Read More
For Patients With Gliomas, Radiopharmaceuticals Used To More Accurately Manage Treatment, Predict Survival
Dec 05, 2012
In the management of gliomas - or tumors that originate in the brain - precise assessment of tumor grade and the proliferative activity of cells plays a major role in determining the most appropriate treatment and predicting overall survival... Read More
The Efficacy Of The German Mammography Screening Program
Dec 05, 2012
How effective is the German mammography screening program? This is the question examined by Oliver Heidinger of the Epidemiological Cancer Registry North Rhine-Westphalia and his co-authors in the first study on this subject in Germany, in Deutsches Arzteblatt International (Dtsch Arztebl Int 2012; 109(46): 781-7). To answer it, the authors have used the interval cancer rate as an indicator... Read More
Previous Page Next Page